‌

US Patent 10646551 Rapid-acting insulin formulation comprising a substituted anionic compound

Patent 10646551 was granted and assigned to Adocia on May, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Adocia

Current Assignee

Adocia

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106465510

Date of Patent

May 12, 2020

Patent Application Number

166873390

Date Filed

November 18, 2019

Patent Citations

‌

US Patent 10172922 Rapid-acting insulin compositions

Patent Citations Received

‌

US Patent 11324808 Rapid-acting insulin formulation comprising a substituted anionic compound

‌

US Patent 10881716 Rapid-acting insulin formulation comprising a substituted anionic compound

Patent Primary Examiner

‌

Dale R Miller

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10646551 Rapid-acting insulin formulation comprising a substituted anionic compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API